Richat Abbas

2.7k total citations
45 papers, 2.1k citations indexed

About

Richat Abbas is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Richat Abbas has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 15 papers in Oncology and 14 papers in Hematology. Recurrent topics in Richat Abbas's work include Chronic Lymphocytic Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers) and HER2/EGFR in Cancer Research (12 papers). Richat Abbas is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers) and HER2/EGFR in Cancer Research (12 papers). Richat Abbas collaborates with scholars based in United States, Italy and France. Richat Abbas's co-authors include Daryl Sonnichsen, Jeffrey W. Fisher, Cathie Leister, Bruce A. Hug, Charles Zacharchuk, Kathleen Turnbull, Poe‐Hirr Hsyu, Christine Powell, Jennifer Vermette and Deirdre A. Mahle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Richat Abbas

44 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richat Abbas United States	22	961	637	587	543	420	45	2.1k
Daryl Sonnichsen United States	23	881 0.9×	337 0.5×	360 0.6×	483 0.9×	200 0.5×	45	1.6k
Paul J. Shami United States	26	506 0.5×	525 0.8×	1.1k 1.9×	1.2k 2.2×	117 0.3×	85	2.7k
Juthamas Sukbuntherng United States	24	490 0.5×	1.3k 2.0×	499 0.9×	541 1.0×	228 0.5×	54	2.2k
Ronald L. Dubowy United States	26	453 0.5×	1.0k 1.6×	589 1.0×	701 1.3×	367 0.9×	67	2.3k
Teresa A. Smolarek United States	26	599 0.6×	109 0.2×	183 0.3×	742 1.4×	528 1.3×	68	2.2k
B Hecquet France	22	887 0.9×	313 0.5×	407 0.7×	641 1.2×	262 0.6×	80	2.2k
Steven D. Reich United States	26	787 0.8×	126 0.2×	261 0.4×	1.0k 1.9×	532 1.3×	73	2.3k
Nunziatina Laura Parrinello Italy	29	546 0.6×	336 0.5×	546 0.9×	738 1.4×	77 0.2×	95	2.0k
Edvardas Kaminskas United States	20	405 0.4×	285 0.4×	513 0.9×	1.2k 2.3×	110 0.3×	33	2.1k
Peter J. Van Veldhuizen United States	34	1.4k 1.5×	122 0.2×	156 0.3×	1.4k 2.6×	1.3k 3.1×	96	3.6k

Countries citing papers authored by Richat Abbas

Since Specialization

Citations

This map shows the geographic impact of Richat Abbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richat Abbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richat Abbas more than expected).

Fields of papers citing papers by Richat Abbas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richat Abbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richat Abbas. The network helps show where Richat Abbas may publish in the future.

Co-authorship network of co-authors of Richat Abbas

This figure shows the co-authorship network connecting the top 25 collaborators of Richat Abbas. A scholar is included among the top collaborators of Richat Abbas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richat Abbas. Richat Abbas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wigal, Sharon B., et al.. (2020). Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 30(2). 104–118. 16 indexed citations

Wigal, Sharon B., Ann Childress, Susan A. Berry, et al.. (2018). Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 28(5). 314–321. 9 indexed citations

Weihs, Karen L., et al.. (2017). Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology. 28(1). 36–46. 26 indexed citations

Atkinson, Sarah, Shannon L. Lubaczewski, Richard D. England, et al.. (2017). Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology. 28(1). 55–65. 23 indexed citations

Lammers, Philip E., et al.. (2017). A randomized, double-blind study of PF-05280014 (a potential biosimilar) vs trastuzumab, both given with docetaxel (D) and carboplatin (C), as neoadjuvant treatment for operable human epidermal growth factor receptor 2-positive (HER2+) breast cancer. Annals of Oncology. 28. v45–v45. 6 indexed citations

Nichols, Alice I., Sam Liao, & Richat Abbas. (2017). Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations. Clinical Pharmacology in Drug Development. 7(4). 441–450. 4 indexed citations

Abbas, Richat, et al.. (2016). Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable Tablet. Clinical Therapeutics. 38(5). 1151–1157. 9 indexed citations

Abbas, Richat & Poe‐Hirr Hsyu. (2016). Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib. Clinical Pharmacokinetics. 55(10). 1191–1204. 55 indexed citations

Abbas, Richat, Joseph Boni, & Daryl Sonnichsen. (2015). Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects. Drug Metabolism and Personalized Therapy. 30(1). 57–63. 26 indexed citations

10.

Abbas, Richat, Glen Park, Bharat Damle, Raul Chertkoff, & Sari Alon. (2015). Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease. PLoS ONE. 10(6). e0128986–e0128986. 9 indexed citations

11.

Abbas, Richat, Cathie Leister, & Daryl Sonnichsen. (2013). A Clinical Study to Examine the Potential Effect of Lansoprazole on the Pharmacokinetics of Bosutinib when Administered Concomitantly to Healthy Subjects. Clinical Drug Investigation. 33(8). 589–595. 25 indexed citations

12.

Abbas, Richat, Bruce A. Hug, Cathie Leister, & Daryl Sonnichsen. (2012). A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor. Cancer Chemotherapy and Pharmacology. 70(1). 191–199. 20 indexed citations

13.

Abbas, Richat, et al.. (2012). Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects. Cancer Chemotherapy and Pharmacology. 71(1). 123–132. 33 indexed citations

14.

Daud, Adil, Smitha Krishnamurthi, Mansoor N. Saleh, et al.. (2011). Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors. Clinical Cancer Research. 18(4). 1092–1100. 68 indexed citations

15.

Abbas, Richat, et al.. (2010). Pharmacokinetics of oral neratinib during co‐administration of ketoconazole in healthy subjects. British Journal of Clinical Pharmacology. 71(4). 522–527. 42 indexed citations

16.

Abbas, Richat, et al.. (2010). Effect of Ketoconazole on the Pharmacokinetics of Oral Bosutinib in Healthy Subjects. The Journal of Clinical Pharmacology. 51(12). 1721–1727. 44 indexed citations

17.

Boni, Joseph, Richat Abbas, Cathie Leister, et al.. (2008). Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus. Cancer Chemotherapy and Pharmacology. 64(2). 263–270. 11 indexed citations

18.

Hijazi, Youssef, et al.. (2004). Pharmacokinetics, Safety, and Tolerability of R411, a Dual α4β1‐α4β7 Integrin Antagonist After Oral Administration at Single and Multiple Once‐Daily Ascending Doses in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(12). 1368–1378. 20 indexed citations

19.

Abbas, Richat & Jeffrey W. Fisher. (1997). A Physiologically Based Pharmacokinetic Model for Trichloroethylene and Its Metabolites, Chloral Hydrate, Trichloroacetate, Dichloroacetate, Trichloroethanol, and Trichloroethanol Glucuronide in B6C3F1 Mice. Toxicology and Applied Pharmacology. 147(1). 15–30. 73 indexed citations

20.

Abbas, Richat & William L. Hayton. (1996). Gas Chromatographic Determination of Parathion and Paraoxon in Fish Plasma and Tissues. Journal of Analytical Toxicology. 20(3). 151–154. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact